Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Simvastatin in patients with progressive multiple sclerosis.
Microglia: Multitasking Specialists of the Brain.
Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study.
Factors influencing the desire to provide MS patient care in clinical practice among physiatrists.
Managing patients with neurologic disorders who participate in sports activities.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Patients with neuromuscular disorder.
Modifiable environmental factors in multiple sclerosis.
RA: from risk factors and pathogenesis to prevention: Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.
Recall strategies for the verbal fluency test in patients with multiple sclerosis.
Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica.
Being Kind to Your Future Self: Probability Discounting of Health Decision-Making.
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.
[Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis].
Differences in Body Composition Across Levels of Disability Among Ambulatory Patients Living With Multiple Sclerosis: 2569 Board #92 June 3, 9: 30 AM - 11: 00 AM.
Neuromuscular manifestations of west nile virus infection.
Your client has multiple sclerosis: understanding the challenge.
Improving drug delivery technology for treating neurodegenerative diseases.
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis.
Use of a physiological profile to document motor impairment in ageing and in clinical groups.
[Neuropathology of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy].
Sphingosine 1-phosphate signaling at the blood-brain barrier.
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis.
Ultrasonographic diagnosis of demyelinating neuropathy.
Pages
« first
‹ previous
…
448
449
450
451
452
453
454
455
456
…
next ›
last »